NDC Package 0007-3387-13 Coreg CR

Carvedilol Phosphate Capsule, Extended Release Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0007-3387-13
Package Description:
30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
Product Code:
Proprietary Name:
Coreg CR
Non-Proprietary Name:
Carvedilol Phosphate
Substance Name:
Carvedilol Phosphate
Usage Information:
Carvedilol is used to treat high blood pressure and heart failure. It is also used after a heart attack to improve the chance of survival if your heart is not pumping well. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This drug works by blocking the action of certain natural substances in your body, such as epinephrine, on the heart and blood vessels. This effect lowers your heart rate, blood pressure, and strain on your heart. Carvedilol belongs to a class of drugs known as alpha and beta blockers.
11-Digit NDC Billing Format:
00007338713
NDC to RxNorm Crosswalk:
  • RxCUI: 860510 - carvedilol phosphate 10 MG 24HR Extended Release Oral Capsule
  • RxCUI: 860510 - 24 HR carvedilol phosphate 10 MG Extended Release Oral Capsule
  • RxCUI: 860510 - carvedilol phosphate 10 MG 24 HR Extended Release Oral Capsule
  • RxCUI: 860512 - COREG CR 10 MG 24HR Extended Release Oral Capsule
  • RxCUI: 860512 - 24 HR carvedilol phosphate 10 MG Extended Release Oral Capsule [Coreg]
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Glaxosmithkline Llc
    Dosage Form:
    Capsule, Extended Release - A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    NDA022012
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    11-01-2019
    End Marketing Date:
    01-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0007-3387-13?

    The NDC Packaged Code 0007-3387-13 is assigned to a package of 30 capsule, extended release in 1 bottle of Coreg CR, a human prescription drug labeled by Glaxosmithkline Llc. The product's dosage form is capsule, extended release and is administered via oral form.

    Is NDC 0007-3387 included in the NDC Directory?

    Yes, Coreg CR with product code 0007-3387 is active and included in the NDC Directory. The product was first marketed by Glaxosmithkline Llc on November 01, 2019.

    What is the 11-digit format for NDC 0007-3387-13?

    The 11-digit format is 00007338713. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20007-3387-135-4-200007-3387-13